Morningside Biopharma

Morningside Biopharma Advisory is a venture-backed biopharmaceutical incubator affiliated with Morningside that builds and operates portfolio companies around prototype therapeutic assets. The organization focuses on infection, immunity, and inflammation and appears to support discovery through early clinical translation using a centralized team spanning research, development, manufacturing, commercial strategy, and business development. Public descriptions indicate that multiple portfolio companies have been formed under this model, including Epsila Bio and Bacainn Therapeutics. The company is better characterized as a biotech incubator and operating platform than as a single-asset drug developer.